Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Astria Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −3 vs. Q3 2021
- Shares held
- 6.09M
- −1.28M (−17.3%) vs. Q3 2021
- Total value
- $32.8M
- −$32.3M (−49.6%) vs. Q3 2021
- New holders
- 5
- 9 more added
- Sold out
- 8
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,281,197 | $6.91M | 0.11% | −678,455−34.6% | Reduced |
| Ra Capital Management, L.P. | 1,262,193 | $6.80M | 0.12% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 911,736 | $4.91M | 1.62% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 552,903 | $2.98M | 0.18% | 00.0% | Unchanged |
| VR Adviser, LLC | 538,999 | $2.90M | 0.40% | 00.0% | Unchanged |
| Vanguard Group Inc | 532,568 | $2.87M | 0.00% | −21,330−3.9% | Reduced |
| Alyeska Investment Group, L.P. | 274,719 | $1.48M | 0.02% | +50,000+22.3% | Added |
| Citadel Advisors LLC | 222,397 | $1.20M | 0.00% | −88,192−28.4% | Reduced |
| Ikarian Capital, LLC | 87,580 | $473.0K | 0.14% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 65,014 | $350.0K | 0.00% | +4,484+7.4% | Added |
| BlackRock Inc. | 53,073 | $287.0K | 0.00% | +11,957+29.1% | Added |
| Bridgeway Capital Management, LLC | 45,000 | $243.0K | 0.00% | +45,000 | New |
| D. E. Shaw & Co., Inc. | 38,207 | $206.0K | 0.00% | −7,863−17.1% | Reduced |
| Renaissance Technologies LLC | 34,361 | $185.0K | 0.00% | −74,992−68.6% | Reduced |
| Artal Group S.A. | 33,333 | $180.0K | 0.01% | 00.0% | Unchanged |
| Botty Investors LLC | 25,747 | $139.0K | 0.04% | −2,500−8.9% | Reduced |
| Samsara BioCapital, LLC | 25,000 | $135.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 22,013 | $119.0K | 0.00% | +2,760+14.3% | Added |
| Oppenheimer & Co Inc | 21,816 | $118.0K | 0.00% | +9,567+78.1% | Added |
| Occudo Quantitative Strategies LP | 15,457 | $83.0K | 0.01% | 00.0% | Unchanged |
| Old Well Partners, LLC | 12,116 | $65.0K | 0.04% | 00.0% | Unchanged |
| Wolverine Trading, LLC | 12,836 | $65.0K | 0.00% | +12,836 | New |
| Millennium Management LLC | 10,259 | $55.0K | 0.00% | +10,259 | New |
| Bank of America Corp | 3,907 | $21.0K | 0.00% | +2,630+206.0% | Added |
| UBS Group AG | 3,247 | $18.0K | 0.00% | +239+7.9% | Added |
| Morgan Stanley | 3,064 | $16.0K | 0.00% | −5−0.2% | Reduced |
| Group One Trading, L.P. | 2,300 | $12.0K | 0.00% | +2,300 | New |
| Tower Research Capital LLC (TRC) | 1,958 | $11.0K | 0.00% | +1,958 | New |
| Benjamin F. Edwards & Company, Inc. | 333 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 64 | $1.00K | 0.00% | +26+68.4% | Added |
| Wells Fargo & Company | 58 | $0 | 0.00% | +1+1.8% | Added |
| Royal Bank of Canada | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 66 | $0 | 0.00% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −239,270−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −156,927−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −112,499−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −24,996−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −11,966−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,221−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −93−100.0% | Sold out |